SCHEMBL5000931

SCHEMBL5000931

CCN(CC)CCOc1ccc(C(C)C(=O)O)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.55
ALDH1A1 P00352 1/20 0.55
ESR1 P03372 4/20 0.54
ESR2 Q92731 2/20 0.54
EBP Q15125 3/20 0.54
SIGMAR1 Q99720 3/20 0.54
CYP2D6 P10635 2/20 0.52
HTT P42858 2/20 0.52
CYP1A2 P05177 1/20 0.52
LTA4H P09960 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
BCHE P06276 1/20 0.51
ACHE P22303 1/20 0.51
KDM4E B2RXH2 2/20 0.50
MAOB P27338 1/20 0.50
AKR1C3 P42330 1/20 0.50
AKR1C2 P52895 1/20 0.50
TSHR P16473 1/20 0.50
ACACB O00763 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7403967 0.83 GPR88 (0.59) ESR1CYP2C9KDM4EAKR1C3AKR1C2
SCHEMBL8403335 0.83 GPR88 (0.59) ESR1CYP2C9KDM4EAKR1C3AKR1C2
SCHEMBL14599721 0.83 GPR88 (0.59) AKR1C3AKR1C2TSHR
SCHEMBL27785772 0.82 HRH3 (0.59) KMT2AALDH1A1ESR1ESR2BCHE
SCHEMBL9827594 0.81 EBP (0.59) KMT2AALDH1A1ESR1ESR2EBP
SCHEMBL12015816 0.81 KDM4E (0.67) KMT2AALDH1A1ESR1ESR2EBP
SCHEMBL9861070 0.80 LMNA (0.62) AKR1C3AKR1C2TSHR
SCHEMBL5881684 0.79 AKR1C3 (0.73) ALDH1A1ESR1CYP1A2CYP2C9AKR1C3
SCHEMBL14599980 0.79 LMNA (0.64) TSHR
SCHEMBL6414796 0.79 LMNA (0.64) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423061-B2 Substitute thiophenes and uses thereof ASTRAZENECA AB (SE) 2008-09-09 US disclosed
US-20060281666-A1 Substitute thiophenes and uses therof ASTRAZENECA AB (SE) 2006-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060281666-A1 Substitute thiophenes and uses therof TYMP, TPMT, MGMT KMT2A 3716/4885ALDH1A1 876/4885ESR1 1776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.